Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 16, 2021, David Diamond notified the Board of Directors (the "Board") of Oncotelic Therapeutics, Inc. (the "Company") of his decision to resign, effective immediately, from his position as a member of the Board. Mr. Diamond also served on the Company's audit committee. Mr. Diamond's resignation did not result from any disagreements with management or the Board.

© Edgar Online, source Glimpses